At present, 15 new crown vaccines have entered clinical trials in China, among which 5 vaccines have entered Phase III clinical trials, including 3 inactivated vaccines, 1 adenovirus vector vaccine and 1 recombinant protein vaccine. In terms of quantity and technical routes covered, China’s new crown vaccines are in the first international ranking. The inactivated vaccines of China’s Sinopharm Zhongsheng and Kexing Zhongwei are the first vaccines to be tested in phase III clinical trials worldwide. Content source: Dr. You Lai